PIMA529176

Carboxypeptidase A1 Monoclonal Antibody (03), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA529176-Each-of-1 In Stock ₹ 32,485.00

PIMA529176 - Each of 1

₹ 32,485.00

In Stock

Quantity

1

Base Price: ₹ 32,485.00

GST (18%): ₹ 5,847.30

Total Price: ₹ 38,332.30

Antigen

Carboxypeptidase A1

Classification

Monoclonal

Concentration

1 mg/mL

Formulation

PBS with no preservative

Gene Accession No.

P15085

Gene Symbols

Cpa1

Immunogen

Recombinant Human Carboxypeptidase A1/CPA1 Protein (Met1-Tyr419)

Quantity

100μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1

Applications

Immunohistochemistry (Paraffin)

Clone

03

Conjugate

Unconjugated

Gene

Cpa1

Gene Alias

0910001L12Rik; carboxypeptidase A; carboxypeptidase A1; carboxypeptidase A1 (pancreatic); carboxypeptidase A1, pancreatic; CPA; Cpa1; pancreatic carboxypeptidase A; pancreatic procarboxypeptidase A

Host Species

Mouse

Purification Method

Protein A

Regulatory Status

RUO

Gene ID (Entrez)

1357

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Related Products

Img

Thermo Scientific

PIMA143024

--

Img

Novus Biologicals

NB011712

--

Img

Thermo Scientific

PIMA531495

--

Img

Novus Biologicals

NB075374

--

Img

Novus Biologicals

NB075383

--

Img

Novus Biologicals

NB075385

--

Img

Novus Biologicals

NB228026

--

Img

Novus Biologicals

NB075398

--

Description

  • This product is preservative free
  • It is recommended to add sodium azide to avoid contamination (final concentration 0.05%-0.1%)
  • This antibody has specificity for Human Carboxypeptidase A1/CPA1
  • CPA1, also known as CPA, is a 419 amino acid secreted monomeric protein that is highly expressed in pancreatic tissue
  • Functioning as a pancreatic exopeptidase, CPA1 uses zinc as a cofactor to catalyze the release of C-terminal amino acids from a variety of proteins, thereby playing a key role in protein digestion and degradation
  • Via its catalytic activity, CPA1 is also thought to be involved in zymogen (proenzyme) inhibition, probably functioning to block enzyme activation pathways
  • Abnormal levels of CPA1 are associated with pancreatic cancer, suggesting a possible role in either tumor progression or tumor suppression events.